Literature DB >> 32029641

Immunotherapy for nonsmall cell lung cancer: a new therapeutic algorithm.

Thierry Berghmans1, Anne-Marie Dingemans2,3, Lizza E L Hendriks2, Jacques Cadranel4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32029641     DOI： 10.1183/13993003.01907-2019

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  7 in total

1.  Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation.

Authors:  Marco Russano; Alessio Cortellini; Raffaele Giusti; Alessandro Russo; Federica Zoratto; Francesca Rastelli; Alain Gelibter; Rita Chiari; Olga Nigro; Michele De Tursi; Sergio Bracarda; Stefania Gori; Francesco Grossi; Melissa Bersanelli; Lorenzo Calvetti; Vincenzo Di Noia; Mario Scartozzi; Massimo Di Maio; Paolo Bossi; Alfredo Falcone; Fabrizio Citarella; Francesco Pantano; Corrado Ficorella; Marco Filetti; Vincenzo Adamo; Enzo Veltri; Federica Pergolesi; Mario Alberto Occhipinti; Linda Nicolardi; Alessandro Tuzi; Pietro Di Marino; Serena Macrini; Alessandro Inno; Michele Ghidini; Sebastiano Buti; Giuseppe Aprile; Eleonora Lai; Marco Audisio; Salvatore Intagliata; Riccardo Marconcini; Davide Brocco; Giampiero Porzio; Marta Piras; Erika Rijavec; Francesca Simionato; Clara Natoli; Marcello Tiseo; Bruno Vincenzi; Giuseppe Tonini; Daniele Santini
Journal:  Cancer Immunol Immunother       Date:  2021-08-31       Impact factor: 6.968

Review 2.  Current Targeted Therapies for the Fight against Non-Small Cell Lung Cancer.

Authors:  Lisa Maria Mustachio; Jason Roszik
Journal:  Pharmaceuticals (Basel)       Date:  2020-11-09

3.  The correlation of WDR76 expression with survival outcomes and immune infiltrates in lung adenocarcinoma.

Authors:  Likui Fang; Guocan Yu; Wenfeng Yu; Gang Chen; Bo Ye
Journal:  PeerJ       Date:  2021-10-04       Impact factor: 2.984

4.  Pseudoprogression in lung cancer: a case report.

Authors:  Giulia Meoni; Nicola Libertà Decarli; Maurizio Benucci; Claudio Raspanti; Angela Stefania Ribecco
Journal:  Explor Target Antitumor Ther       Date:  2020-10-30

Review 5.  Biomedical Applications of Non-Small Cell Lung Cancer Spheroids.

Authors:  Julian M Rozenberg; Gleb I Filkov; Alexander V Trofimenko; Evgeny A Karpulevich; Vladimir D Parshin; Valery V Royuk; Marina I Sekacheva; Mikhail O Durymanov
Journal:  Front Oncol       Date:  2021-12-07       Impact factor: 6.244

6.  Identification of Potential Prognostic and Predictive Immunological Biomarkers in Patients with Stage I and Stage III Non-Small Cell Lung Cancer (NSCLC): A Prospective Exploratory Study.

Authors:  Rianne D W Vaes; Kobe Reynders; Jenny Sprooten; Kathleen T Nevola; Kasper M A Rouschop; Marc Vooijs; Abhishek D Garg; Maarten Lambrecht; Lizza E L Hendriks; Marijana Rucevic; Dirk De Ruysscher
Journal:  Cancers (Basel)       Date:  2021-12-13       Impact factor: 6.639

Review 7.  Patient Selection for Local Aggressive Treatment in Oligometastatic Non-Small Cell Lung Cancer.

Authors:  Raphael S Werner; Isabelle Opitz
Journal:  Cancers (Basel)       Date:  2021-12-19       Impact factor: 6.639
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.